Newcastle Disease, Avian Influenza (Subtype H9) , Fowl Adenovirus And Infectious Bursal Disease Four-valent Vaccine, Inactivated
- China’s top vaccine factory
- Support Inspection Factory
- OEM/ODM, Wholesale
- Certificate: ISO, CQC, GMP, FDA
- On-Time Delivery
- Free Sample
- 7/24 Hours Free Customer Service
Generic name of product
Newcastle Disease, Avian Influenza (Subtype H9) , Fowl Adenovirus And Infectious Bursal Disease Four-valent Vaccine, Inactivated
Main Ingredients and Content
The vaccine contains the inactivated Newcastle Disease Virus (sub-genotype VII) with a viral titer of ≥ 3×109.0EID50/0.1ml (before inactivation), the inactivated Avian Influenza Virus (H9N2 subtype clade 4.1.a and 4.1.b) both with a viral titer of ≥ 3×109.0EID50/0.1ml (before inactivation), Fowl Adenovirus subunit antigen concentration：Fibre protein Type C4≥108.5TCID50/0.1ml, Fibre proteinType E 8a/8b≥108.0TCID50/0.1ml, Fibre protein Type D11≥108.0TCID50/0.1ml.the VP2 protein content of Infectious Bursal Disease Virus in is 10μg /0.1 mL.
Character
Milky white uniform emulsion
Functions and Uses
Used for the prevention of Newcastle Disease(sub-genotype VII),Avian Influenza (H9N2 subtype clade 4.1.a and 4.1.b),Fowl Adenovirus（I GROUP Type C4、TypeE 8a/8b、Type D11) and Infectious Bursal Disease Virus. Immunity is generated 14–21 days after immunization, with an immune period of 3 months.
Usage and Dosage
Administer via subcutaneous injection in the neck or intramuscular injection.
For chickens aged 1-4 weeks: 0.3ml/dose
For chickens over 4 weeks of age: 0.5ml/dose
Adverse Reactions
Generally, no visible adverse reactions occur
Precautions
- 1. Inoculate healthy chickens only. It is forbidden to use in emaciated and diseased chickens.
- 2. Check carefully for broken bottles, absent label, impurity in vaccine, severe separation of water phase and oil phase, and other abnormal conditions before use, if any, do not use.
- 3. Allow the vaccine to room temperature and shake well before use.
- 4. After the vaccine bottle is first opened, use up the vaccine within 2 hours, avoiding contamination.
- 5. The vaccine shouldn’t be frozen.
- 6. Instruments such as the needles and syringes for the injection of the product need to be disinfected by pressured steam or boiling.
- 7. The vaccine should be combined with live Newcastle disease and infectious bronchitis vaccines to improve cell-mediated immunity and mucosal immunity.
Storage and Period of Validity
2-8℃ preservation, valid for 24 months.
Specifications
(1)250mL/bottle, 40bottles/carton (2)500mL/bottle, 20bottles/carton
Only under the guidance of the veterinary use
Features
1.One injection provides four protections – an innovative breakthrough in China that improves disease prevention efficiency, enhances effectiveness, and reduces farm workload.
2.Serotype-matched, highly concentrated viral subunit antigens formulated in scientifically optimized proportions.
3.Adjuvant formulation ensures zero stress and delivers high-efficiency protection using compound vegetable oil technology.
4.The adoption of a customized H9 Avian Influenza strain model enables meeting the needs of different countries for prevalent strains.
5.The vaccine contains composite antigens from classical very virulent Infectious Bursal Disease virus (cvvIBDV) and novel variant IBDV (nvIBDV), offering improved cross-protection against both strains as an upgraded version of the company’s original inactivated IBD vaccine series.
Recommended Vaccination Schedule
| Vaccine Name | Immune Age | Immune Dose (ml) |
|---|---|---|
| ND+AI+FADV+IBD | 1 d or 7–10 d | 0.2 or 0.3 |